Skip to content

Association of Hb F Level With Clinical Severity of Beta Thalassemia

Association of Hb F Level With Clinical Severity of Beta Thalassemia

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04917978
Enrollment
1200
Registered
2021-06-08
Start date
2019-12-01
Completion date
2025-12-30
Last updated
2021-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Beta Thalassemia

Brief summary

The production of Hb F after birth is an important factor in modifying the clinical severity of beta thalassemia because an increased gamma-globin level will bind the additional a-globin and form Hb F. The objective of this project is to evaluate the association of Hb F level with phenotypic diversity of patients with beta thalassemia.

Interventions

DIAGNOSTIC_TESTHematological Phenotype Analysis

Hematological parameters were determined with an automated hematology analyzer (Sysmex, Japan), and hemoglobin analysis was performed with either high-performance liquid chromatography (Bio- Rad, USA) or capillary electrophoresis (Sebia, France and Helena, USA).

Sponsors

ZhuHai Hospital
CollaboratorOTHER
Shenzhen Children's Hospital
CollaboratorOTHER_GOV
Shenzhen Second People's Hospital
CollaboratorOTHER
Jiangmen Maternity and Child Health Care Hospital
CollaboratorUNKNOWN
Yongzhou Maternity and Child Health Hospital
CollaboratorUNKNOWN
Nanfang Hospital, Southern Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Diagnosed with beta-thalassemia

Exclusion criteria

* Iron Deficiency Anemia

Design outcomes

Primary

MeasureTime frameDescription
Hb F level and severity of anemia3 yearsObservational study that analyzed association of Hb F level and anemia severity in patients

Countries

China

Contacts

Primary ContactXiangmin Xu, Prof. Dr.
xixm@smu.edu.cn02061648293

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026